Industry News


Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info



Global Medical Nonwoven Disposables Market To Reach $12 Billion By 2010

As per the report titled "Medical Nonwoven Disposables: A Global Strategic Business Report" published by Global Industry Analysts, Inc., Nonwoven disposables are rapidly making inroads into the medical sector, principally driven by growing consumer awareness against spread of infectious diseases such as AIDS and Hepatitis.

The United States is the largest medical nonwovens market in the world and is projected to exceed $3.4 billion by the year 2010, as stated by Global Industry Analysts, Inc. With the volume of sophisticated hi-tech surgical intervention growing rapidly, Europe is projected to experience high growth in medical nonwovens sector in the coming years. Alternatively, Asia-Pacific offers massive potential in the long run largely driven by some of the fastest growing global economies, including China and India.

About 3.3 billion square yards of nonwoven material is used in medical and surgical applications in North America alone. This indicates the potential of the market lying ahead and opens up newer revenues for the producers. Among product segments, surgical nonwoven products market is the largest and the fastest growing segment and is projected to cross $5.0 billion by the year 2010.

Key players dominating the global medical nonwoven disposables market include Ahlstrom Corporation, Asahi Kasei Corporation, Attends Healthcare Products, Buckeye Technologies, Covidien, DUPONT, Fiberweb Plc, Freudenberg Nonwovens, Hogy Medical, Kao Corporation, Kimberly-Clark Corporation, Medline Industries, Molnlycke Health Care, Nissan Medical Industries, Polymer Group, Precision Fabrics Group, SCA Hygiene Products, THE HARTMANN GROUP, and UniCharm Corp.

Reference : Healthcare Purchasing News, May, 2008,

German Firm Invests Rs 110 Cr In India

Germany-based medical device manufacturer B Braun has earmarked Rs 110 crore (16 million euros) budget for expanding its operations in India and is targeting a revenue of around Rs 250 crore by 2010.     

"We have invested eight million euros (Rs 55 crores) for setting up a manufacturing plant in Chennai and will pump in another eight million euros in expanding its capacity in the next two years," B Braun Vascular System Senior Vice-President Gerd Wacker told PTI.     

The company has formed a subsidiary 'B Braun Medical India Pvt Ltd' to look after its business in India.     

It has got the approval of Drug Controller General of India (DCGI) for introducing around 12 medical devices across different therapeutic areas and is also waiting for DCGI nod to introduce another five products in the country.     

Apart from hospital care, the company is operating in India in anasthetics and Surgical instruments.     

B Braun has set up a manufacturing unit in Chennai for manufacturing cardiovascular equipments. From this centre the company exports devices to other countries, too.      Besides this, the company is also initiating a phase IV clinical trial for its medical device 'drug eluting balloons' used in the treatment of heart arteries and has plans to launch it in the next year.It also announced the launch of its next generation device 'drug eluting stent' (DES) used for the treatment of defected coronaries.     

"In 2008, we are expecting a revenue of Rs 160 crore and by 2010, when all our projects would start contributing to our revenues, it should cross Rs 250 crore," B.Braun Medical India Business Unit Manager Vascular System Indranil Mukherji said. 



Other News

Johnson & Johnson expects growth in hip replacement products, medical devices through 2012
Solvay Advanced Polymers Commissions New PEEK Plant in India
Trivitron JVs with intl cos. to set up India's first Medical Technology Park (MTP)
Medical Devices Made with Tainted Heparin Recalled by Medtronic
Italy-India forum focuses on technology co-operation
Biocon Launches Pre-Filled Safety Syringe
Siemens To Install India's 1st Magnetom Essenza At Aatmajyoti MRI Center
DES From Abbott Outperforms Market-Leading Stent
FDA Claims To Approve Medical Devices Faster
Essel Propack: Acquisition In Medical Devices
Medical Devices, The Next Big Step For Semiconductor Makers





Back | Back To Top | Previous | Next